KSKarri Suvila

Karri Suvila

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karri Suvila has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and clinical characteristics of secondary hypertension in young hypertensive tertiary care patients

    by Jasmin Vesamo, Teemu J. Niiranen, Karri Suvila

    Current European guidelines recommend screening <30-year-old hypertensive patients for secondary hypertension, but the evidence behind this recommendation is limited. Our objective was to assess secondary hypertension prevalence and etiology among young adults and to determine the characteristics linked with secondary hypertension in these patients. We retrospectively studied 243 Finnish hypertensive adults aged 16–30 years (mean age 25.5 years; 49% women) evaluated at a tertiary care hospital in Finland between 2002 and 2023. Data were collected from electronic health records. Patients were classified under three hypertension subtypes: primary, secondary, or exogenic hypertension. We examined the association between participants characteristics and hypertension subtype (primary versus secondary) using logistic regression. A total of 133 patients had primary hypertension, while 98 patients had secondary hypertension. The most common causes of secondary hypertension were renal disease (n = 77) and sleep apnea (n = 13), whereas other causes were limited to 1–2 cases. Individuals with diabetes mellitus had odds of 2.79 (95% confidence interval [95% CI], 1.21-6.43; P = 0.02) for having secondary versus primary hypertension. A plasma creatinine increase of 1 mmol/l was associated with 1.03-fold (95% CI 1.01–1.04; P = 0.002) odds of secondary hypertension. Apart from renal disease and sleep apnea, other forms of secondary hypertension are extremely rare in young adults with hypertension. In this population, renal parenchymal disease and diabetes mellitus emerged as the most important risk factors for secondary hypertension. Extensive universal screening for secondary hypertension without suspicion of such condition for all hypertensive patients <30 years may be unnecessary.


  • Open Access

    Clinical Correlates of Early-Onset Hypertension

    by Karri Suvila, Joao A C Lima, Susan Cheng, Teemu J Niiranen

    Early-onset hypertension has been established as a heritable trait and a risk factor for cardiovascular disease outcomes. However, the clinical correlates of early-onset hypertension remain unidentified. In this study, we assessed the demographic characteristics and lifestyle factors related to hypertension onset age in a sample of 3,286 Coronary Artery Risk Development in Young Adults (CARDIA) study participants (mean baseline age 25 ± 4 years, 57% women). We examined the association between the participants’ baseline characteristics and age of hypertension onset subgroups (P < 0.05 for trend for both). Our findings suggest that individuals who are black, obese, have higher total cholesterol, or have lower HDL-cholesterol level, are potentially at an increased risk of having early-onset hypertension.


  • Open Access

    SEX DIFFERENCES IN THE GENETIC RISK FOR HYPERTENSION

    by Jenni Aittokallio, Anni Kauko, Felix Vaura, Karri Suvila, Susan Cheng, Teemu Niiranen

    Objective: The development of hypertension differs markedly between men and women. The genetic drivers of this difference have not been fully studied. Genome-wide polygenic risk scores (PRSs), consisting of data from up to 6 M single nucleotide polymorphisms have been shown to considerably improve hypertension risk prediction, particularly in early-onset disease. However, the sex differences in the ability of PRSs to predict hypertension has not been studied previously. Figure Survival curves from Cox proportional hazards models illustrate the cumulative risk of hypertension by systolic blood pressure PRS categories in FinnGen for women and men. We observed 123 579 women and 95 213 men with 27 804 and 28 113 cases of incident hypertension, respectively. Design and method: Our study sample comprised 218792 FinnGen Study participants with lifetime register-based follow-up for incident hypertension (56% women, mean age 58 years). We used publicly available genome-wide association results from UK Biobank to compute sex-specific PRSs for systolic blood pressure. We categorized SBP PRS into five bins according to percentiles ( 97.5) and used middle bin as the reference. We used multivariable-adjusted Cox proportional hazards models to measure the association between the PRSs and incident hypertension. Results: The PRS was more strongly associated with incident hypertension in women than in men (Figure). The hazard ratios (HR) per 1 SD increase in PRSs were 1.42 (95% CI, 1.40–1.44) for women and 1.27 (95% CI, 1.26–1.29) with an interaction P-value of 4x10–29. The difference between women (HR, 1.56; 95% CI, 1.53–1.58) and men (HR, 1.35; 95% CI, 1.32–1.37) was even greater for early-onset hypertension (onset at age < 55 years). Men and women in the top 2.5 PRS percentile had 2.1-fold (95% CI, 2.0–2.3) and 1.8-fold (95% CI, 1.7–1.9) greater risks of developing hypertension than the reference group. Conclusions: The genetic risk of hypertension appears to be more distinctive in women than in men, which may reflect physiological differences starting already at an early age. These results emphasize the use of sex-specific PRSs in clinical prediction of hypertension.

  • Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk

    by Felix Vaura, Anni Kauko, Karri Suvila, Aki S Havulinna, Nina Mars, Veikko Salomaa, Susan Cheng, Teemu Niiranen

    Although genetic risk scores have been used to predict hypertension, their utility in the clinical setting remains uncertain. Our study comprised N=218 792 FinnGen participants (mean age 58 years, 56% women) and N=22 624 well-phenotyped FINRISK participants (mean age 50 years, 53% women). We used public genome-wide association data to compute polygenic risk scores (PRSs) for systolic and diastolic blood pressure (BP). Using time-to-event analysis, we then assessed (1) the association of BP PRSs with hypertension and cardiovascular disease (CVD) in FinnGen and (2) the improvement in model discrimination when combining BP PRSs with the validated 4- and 10-year clinical risk scores for hypertension and CVD in FINRISK. In FinnGen, compared with having a 20 to 80 percentile range PRS, a PRS in the highest 2.5% conferred 2.3-fold (95% CI, 2.2–2.4) risk of hypertension and 10.6 years (95% CI, 9.9–11.4) earlier hypertension onset. In subgroup analyses, this risk was only 1.6-fold (95% CI, 1.5–1.7) for late-onset hypertension (age ≥55 years) but 2.8-fold (95% CI, 2.6–2.9) for early-onset hypertension (age <55 years). Elevated systolic BP PRS also conferred 1.3-fold (95% CI, 1.2–1.4) risk of CVD and 2.3 years (95% CI, 1.6–3.1) earlier onset. In FINRISK, systolic and diastolic BP PRSs improved clinical risk prediction of hypertension (but not CVD), increasing the C statistics by 0.7% (95% CI, 0.3–1.1). We demonstrate that genetic information improves hypertension risk prediction. BP PRSs together with traditional risk factors could improve prediction of hypertension and particularly early-onset hypertension, which confers substantial CVD risk.


  • Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function

    by Karri Suvila, Joao A.C. Lima, Yuichiro Yano, Zaldy S. Tan, Susan Cheng, Teemu J. Niiranen

    Hypertension is related to increased risk of cognitive decline in a highly age-dependent manner. However, conflicting evidence exists on the relation between age of hypertension onset and cognition. Our goal was to investigate the association between early- versus late-onset hypertension and midlife cognitive performance in 2946 CARDIA study (Coronary Artery Risk Development in Young Adults) participants (mean age 55±4, 57% women). The participants underwent 9 repeat examinations, including blood pressure measurements, between 1985 to 1986 and 2015 to 2016. The participants underwent brain magnetic resonance imaging and completed Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Stroop interference test, and the Montreal Cognitive Assessment to evaluate cognitive function at the year 30 exam. We assessed the relation between age of hypertension onset and cognitive function using linear regression models adjusted for cognitive decline risk factors, including systolic blood pressure. We observed that individuals with early-onset hypertension (onset at P 0.05 for all). In a subgroup of 559 participants, neither early- nor late-onset hypertension was related to macrostructural brain alterations ( P  >0.05 for all). Our results indicate that early-onset hypertension is a potent risk factor for midlife cognitive impairment. Thus, age of hypertension onset assessment in clinical practice could improve risk stratification of cognitive decline in patients with hypertension.


  • Association between self-reported hypertension onset age and electrocardiographic left ventricular hypertrophy

    by Arttu O. Lehtonen, Karri Suvila, Antti M. Jula, Teemu J. Niiranen

    Objectively defined early-onset hypertension, based on repeated blood pressure measurements, is associated with greater odds of organ damage and cardiovascular mortality than late-onset hypertension. In this study we examined the association between two factors that are easily available in primary care, self-reported hypertension onset age and electrocardiographic left ventricular hypertrophy (ECG-LVH), in a nationwide population sample of 2864 Finns aged ≥50 years. We observed that, in contrast to prior findings, the odds of ECG-LVH were similar between self-reported hypertension onset age groups, and thus self-reported early-onset hypertension does not seem to associate with ECG-LVH more strongly than simple presence of hypertension.


  • Open Access

    Age of Hypertension Onset: Overview of Research and How to Apply in Practice

    by Karri Suvila, Ville Langén, Susan Cheng, Teemu J. Niiranen

    Purpose of Review: To review the current evidence on research related to age of hypertension onset—its definition, correlates, heritability, and association with adverse outcomes. We also propose a framework for implementing assessment of hypertension onset age into clinical practice. Recent Findings: Prior studies have used both objective measurements and self-report to determine age of hypertension onset or early-onset hypertension. Yet, no criterion for standard definition currently exists for either. Data from epidemiological and clinical studies demonstrate that early-onset hypertension is a highly heritable trait that confers an increased risk for cardiovascular death and end-organ damage compared with late-onset hypertension. Summary: Literature to date suggests that (parental) age of hypertension onset can be feasibly assessed for estimating (1) risk of future hypertension in non-hypertensive persons; and (2) the propensity for cardiovascular disease in individuals with established hypertension.


  • Early-Onset Hypertension

    by Teemu J. Niiranen, Karri Suvila, Susan Cheng